Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

EOAI3402143 is an inhibitor of ubiquitin-specific protease 9X (USP9X), USP24, and USP5.1 It inhibits the catalytic domain of USP9X (IC50 = 1.6 µM). EOAI3402143 (5 µM) inhibits USP9X, USP24, and USP5 in MM.1S multiple myeloma cells. It inhibits the growth of vemurafenib-sensitive and -resistant A375 melanoma cells (IC50s = 1 µM).2 In vivo, EOAI3402143 (15 mg/kg) reduces tumor volume in MM.1S and A375 mouse xenograft models.1,2
WARNING This product is not for human or veterinary use.
1. Targeting deubiquitinase activity with a novel small-
2. Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathway. Oncotarget 5(14), 5559-5569 (2014).